Hypofractionation Trial of Re-irradiation in Good Prognosis Recurrent Glioblastoma

Abroad (travel likely)RecruitingPHASE1

Conditions

Astrocytoma · Glioma · Recurrent Glioblastoma

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

National Institutes of Health Clinical Center, Bethesda, Maryland, United States
Contact: Study coordinator (National Cancer Institute Referral Office) · 888-624-1937

Study leads

Peter GK Mathen, M.D.
Principal Investigator
National Cancer Institute (NCI)

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Implantable Microdevice In Primary Brain Tumors

Grade II Glioma · Grade III Glioma · Grade IV Glioma

Abroad (travel likely)RecruitingEARLY_PHASE1

Boston, United States

Super Selective Intra-arterial Repeated Infusion of Cetuximab (Erbitux) With Reirradiation for Treatment of Relapsed/Refractory GBM, AA, and AOA

Glioblastoma · Anaplastic Astrocytoma · Anaplastic Oligoastrocytoma

Abroad (travel likely)RecruitingPHASE2

New York, United States

Study of an AAV Mediated Dual-Payload Gene Therapy in Patients With High Grade Glioma

Glioblastoma (GBM) · High Grade Gliomas · Recurrent Glioblastoma

Abroad (travel likely)RecruitingPHASE1, PHASE2

Columbus, United States · Edinburgh, United Kingdom

PLX038 in Primary Central Nervous System Tumors Containing MYC or MYCN Amplifications

Glioma · Medulloblastoma · Ependymoma

Abroad (travel likely)RecruitingPHASE1, PHASE2

Bethesda, United States